Search Results

Displaying Results 51-75 of 284 "'GIL'"

Jul 11, 2026, 14:05 ET 18. Biennale für zeitgenössische Kunst in Lyon

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 11, 2026, 10:20 ET 18वीं Lyon Biennale Contemporary Art

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 11, 2026, 08:05 ET Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026

https://clinicaltrials.gov/study/NCT05878938.Lentz S, Chowedary P, Gil L, et al. FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic.

More news about: Novo Nordisk


Jul 11, 2026, 08:05 ET Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026

https://clinicaltrials.gov/study/NCT05878938.Lentz S, Chowedary P, Gil L, et al. FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic.

More news about: Novo Nordisk


Jul 10, 2026, 11:08 ET 18ª Bienal de Arte Contemporáneo de Lyon

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 10, 2026, 09:00 ET 18e Biennale de Lyon Art contemporain

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 10, 2026, 07:41 ET 18th Lyon Biennale Contemporary Art

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 10, 2026, 07:32 ET 18th Lyon Biennale Contemporary Art

Boer & Latifa Laâbissi, George Brecht, Luz Broto, Laia Estruch, EVA & ADELE, Charles-Arthur Feuvrier Fok-Shan [JCI], Maja Fredin [JCI], Karlos Gil, Haonan He [JCI], Daphné Hérétakis, Gideon Horváth, Joyce Joumaa [JCI], Maxime Jean-Baptiste, Anda Kryeziu, Germaine Kruip, Marine Lanier*, Katya Lesiv,

More news about: Artmarket.com


Jul 09, 2026, 17:43 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gildan Activewear Inc. - GIL

2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gildan Activewear Inc. ("Gildan" or the "Company") (NYSE: GIL). Such investors are advised to contact Danielle Peyton at [email protected] or

More news about: Pomerantz LLP


Jul 09, 2026, 07:00 ET Matricelf Continues Clinical Execution with Patient Enrollment Preparation Following GLP Safety Success and GMP Manufacturing Milestones

Health."This approval is another meaningful step in our systematic transition from advanced preclinical development into the clinic," said Gil Hakim, Chief Executive Officer of Matricelf. "Partnering with Loewenstein Medical Center, Israel's leading spinal cord injury rehabilitation hospital,

More news about: Matricelf Ltd.


Jul 09, 2026, 03:10 ET Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL

Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Gildan Activewear Inc. (NYSE: GIL) resulting from allegations that Gildan Activewear may have issued materially misleading business information to the investing public.So What:

More news about: THE ROSEN LAW FIRM, P. A.


Jul 06, 2026, 16:14 ET Newmark Arranges $515 Million Refinancing for Rithm Capital's 31 West 52nd Street in Midtown Manhattan

ownership continue to make it an attractive investment for lenders seeking exposure to best-in-class office assets.Cushman & Wakefield's Gideon Gil, Zach Kraft and Cecelia Galligan also advised on the transaction.About NewmarkNewmark Group, Inc. (Nasdaq: NMRK), together with

More news about: Newmark Group, Inc.


Jul 06, 2026, 05:30 ET Katten Enters Miami Market with Prominent Capital Markets Hire from DLA Piper

proven leader with strong relationships and a market-leading practice in one of the country's most compelling business centers," said Katten Chairman Gil Soffer. "The opening of our Miami office allows us to deliver Katten's full capabilities to clients in South Florida and it reflects our commitment to

More news about: Katten


Jul 02, 2026, 11:42 ET Edge226 Acquires AnyClip Ltd. to Power the Future of AI-Powered Cross-Channel Performance Marketing

publishers.Together, we are building the next generation of AI-powered performance marketing across video, CTV, mobile, and emerging digital channels."Gil Becker, CEO of AnyClip"This transaction marks an important milestone in AnyClip's journey. Over the years, we have built a strong business,

More news about: Edge226


Jul 02, 2026, 05:00 ET Award-Winning Author, Luz Mack, Launches The Missing Book Podcast, Exploring the Power of Representation, Literacy and the People Behind the Books

Cruzado, children's book author, PreK–2 education leader, and author of Coco! Cherry! Mango!.Episode 7: Lisa Gil-Ventura, poet, essayist, teaching artist, educator and author of ¿Con qué papel me envuelves la luna?Episode 8 will feature Dr.

More news about: Luz Maria Mack


Jul 01, 2026, 14:14 ET Gildan Activewear Inc. (GIL) Shares Tumble 18% Amid Activist Forensic Report Challenging Company's Business Practices And Potentially Improper Revenue Recognition -- HBSS

www.hbsslaw.com/investor-fraud/gil Contact the Firm Now: [email protected]                                        844-916-0895Gildan Activewear Inc. (GIL) Investigation:Gildan

More news about: Hagens Berman Sobol Shapiro LLP


Jun 30, 2026, 12:57 ET Atera Extends Enterprise Lead with Top G2 Rankings

deployment through measurable business outcomes."These milestones reflect a broader shift in how enterprise teams adopt and evaluate AI," said Gil Pekelman, co-founder and CEO of Atera. "Organizations are moving beyond the theoretical promise of AI and focusing on measurable impact in practice.

More news about: Atera


Jun 30, 2026, 06:21 ET $GIL Notification: Gildan Investigated for Misrepresentations about its Revenue Sources after 18% Stock Drop

multimedia:https://www.prnewswire.com/news-releases/gil-notification-gildan-investigated-for-misrepresentations-about-its-revenue-sources-after-18-stock-drop-302814052.htmlSOURCE

More news about: Bleichmar Fonti & Auld LLP


Jun 29, 2026, 20:35 ET Rosen Law Firm Encourages Gildan Activewear Inc. Investors to Inquire About Securities Class Action Investigation - GIL

Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Gildan Activewear Inc. (NYSE: GIL) resulting from allegations that Gildan Activewear may have issued materially misleading business information to the investing public.So What:

More news about: THE ROSEN LAW FIRM, P. A.


Jun 26, 2026, 08:00 ET NVTC Launches New Strategic Plan and Elects Board Leadership at 35th Annual Meeting

vacancies in the Class of 2028, and elected nine FY2027 Chair Appointees. The Board also elected its FY2027 Officers for a two-year term, including Gil Dussek, CEO of Gunnison, as Chair. These incoming Board members and officers will help guide implementation of the strategic plan and advance NVTC's

More news about: Northern Virginia Technology Council


Jun 25, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gildan Activewear Inc. - GIL

2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Gildan Activewear Inc. ("Gildan" or the "Company") (NYSE: GIL). Such investors are advised to contact Danielle Peyton at [email protected] or

More news about: Pomerantz LLP


Jun 24, 2026, 20:30 ET NAVER D2SF Invests in SAZO, a Cross-Border Agentic Commerce Startup

June 24, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a new investment in SAZO (CEO, Maro Gil), a cross-border commerce startup building agentic AI-powered infrastructure for global shopping. SAZO has developed a platform where AI agents automate

More news about: NAVER D2SF


Jun 24, 2026, 10:07 ET Gildan Activewear (GIL) Securities Fraud Investigation - Levi & Korsinsky

Report.Frequently Asked Questions About the GIL Investigation Q: What is the GIL securities fraud investigation about? A: A securities fraud investigation has been initiated concerning Gildan Activewear (NYSE: GIL) regarding potentially materially false and misleading

More news about: Levi & Korsinsky, LLP


Jun 24, 2026, 10:00 ET PCS Retirement Appoints Gil Amoray Chief Operating Officer

2026 /PRNewswire/ -- PCS Retirement, one of the nation's largest independent retirement plan recordkeepers, today announced the appointment of Gil Amoray as Chief Operating Officer.

More news about: PCS Retirement, LLC


Jun 24, 2026, 10:00 ET West Monroe Introduces Clonal™, an Operational Intelligence Platform Designed to turn Fragmented Operations into Real-Time Business Performance

Gil Mermelstein, West Monroe's CEO. "Clonal™ was built to solve that challenge, not just through technology, but through a deployment model that combines

More news about: West Monroe


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.